1993
DOI: 10.1111/j.1365-2133.1993.tb15161.x
|View full text |Cite
|
Sign up to set email alerts
|

Tranexamic acid (CyklokapronR)-induced fixed-drug eruption

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

1995
1995
2016
2016

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(8 citation statements)
references
References 3 publications
0
8
0
Order By: Relevance
“…This was attributed to tranexamic acid and was unresponsive to graded introduction of TXA on 2 occasions, with rashes appearing with doses as low as 25 micrograms [6]. …”
Section: Discussionmentioning
confidence: 99%
“…This was attributed to tranexamic acid and was unresponsive to graded introduction of TXA on 2 occasions, with rashes appearing with doses as low as 25 micrograms [6]. …”
Section: Discussionmentioning
confidence: 99%
“…No mutagenic activity or harmful fetal effects have been reported . Adverse events that have been reported include anaphylactic shock, skin reaction, and acute renal cortical necrosis . TA has no effect on coagulation parameters.…”
Section: Properties Of Ta and Its Safety Profilementioning
confidence: 99%
“…To date, fixed drug eruption caused by tranexamic acid is rarely reported in English literatures. [ 1 ] Fixed drug eruption appears as solitary or multiple well-circumscribed, rounded erythematous macules. The pathogenesis of fixed drug eruption is not fully elucidated as yet; however, the resting lesions of previously affected sites contain a number of CD8-positive T cells in the basal layers of the epidermis, which play a major role in the epidermal injury via interferon-γ (IFN-γ).…”
Section: Discussionmentioning
confidence: 99%